A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma)

Affiliations

• ¹ Division of Hematology-Oncology, Department of Pediatrics, CHU Sainte-Justine, Montréal, QC, Canada.
• ² Molecular Diagnostic Laboratory, CHU Sainte-Justine, Montréal, QC, Canada.
• ³ Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada.
• ⁴ Centre Hospitalier Universitaire de Sherbrooke, Université Sherbrooke, Sherbrooke, QC, Canada.
• ⁵ Hôpital de l'Enfant Jésus, CHU de Québec, Québec, QC, Canada.
• ⁶ Montreal Children's Hospital, McGill University Health Center, Montréal, QC, Canada.
• ⁷ Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.